# The Efficacy of Prolonged Antibiotic Therapy for the Prevention of Relapsing Peritonitis in Peritoneal Dialysis Patients With High Dialysis Effluent Bacterial DNA Fragment Levels

> **NCT02593201** · PHASE4 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 358 (actual)

## Conditions studied

- Peritoneal Dialysis

## Interventions

- **DRUG:** Extended antibiotics (cefazolin or ceftazidime)
- **DRUG:** Usual antibiotics (cefazolin or ceftazidime)

## Key facts

- **NCT ID:** NCT02593201
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-26
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-06-30
- **Target enrollment:** 358 (ACTUAL)
- **Last updated:** 2019-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02593201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02593201, "The Efficacy of Prolonged Antibiotic Therapy for the Prevention of Relapsing Peritonitis in Peritoneal Dialysis Patients With High Dialysis Effluent Bacterial DNA Fragment Levels". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02593201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*